Comparing the current results to its competitors, Atrion reported Revenue increase in the 2 quarter 2024 by 11.26 % year on year. The sales growth was above Atrion's competitors' average revenue growth of 4.8 %, achieved in the same quarter.
Atrion's Comment on Competition and Industry Peers
The company operates in a healthcare products market characterized by competition from established manufacturers with broader product lines, greater distribution capabilities, larger capital resources, and more extensive marketing and research and development staffs and facilities. Competitors often offer wider product ranges within specific markets and the broader medical devices and supplies sector, allowing them to secure exclusive, long-term supply contracts and provide comprehensive pricing options. The company competes through engineering and design expertise, quality, service, product offerings, and pricing, relying on its reputation and expertise to sustain long-term customer relationships. Intellectual property litigation is common in the industry and can serve as a competitive tool, though it is complex, costly, and unpredictable.
Company's competitiveness improved within Overall company, with revenue growth of 11.26 % and its market share increased to approx. 0.15 %. << More on ATRI Market Share.
*Market share is calculated based on total revenue.
Inari Medical Inc is a medical technology company that specializes in providing minimally invasive treatments for venous diseases. Their business model revolves around developing and commercializing innovative devices used in treating deep vein thrombosis and pulmonary embolism. By focusing on developing advanced, user-friendly solutions, Inari Medical aims to improve patient outcomes and provide healthcare professionals with effective tools to address venous diseases.
Merit Medical Systems Inc operates as a medical device company that develops, manufactures, and distributes disposable medical devices. Their business model focuses on delivering high-quality and innovative products to healthcare professionals and hospitals worldwide. They generate revenue through the sales and distribution of their medical devices, aiming to improve patient outcomes and provide value to healthcare providers.
Meihua International Medical Technologies Co Ltd Share Performance
-66.48%
30 Days
Meihua International Medical Technologies Co Ltd
Profile
Meihua International Medical Technologies Co. Limi operates on a business model focused on the development and distribution of medical technologies and solutions. The company aims to deliver innovative and quality medical equipment to healthcare providers and institutions globally. By leveraging their expertise and partnerships, Meihua strives to enhance healthcare outcomes and contribute to the advancement of medical technology.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Sources:
Atrion Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Atrion Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
